Alkermes
ALKS
#2351
Rank
โ‚น719.48 B
Marketcap
โ‚น4,282
Share price
-2.03%
Change (1 day)
65.24%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2026 (TTM): -โ‚น0.87

According to Alkermes's latest financial reports the company's current EPS (TTM) is -โ‚น0.0000000000. In 2025 the company made an earnings per share (EPS) of โ‚น137.12 a decrease over its 2024 EPS that were of โ‚น208.01.

EPS history for Alkermes from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น0.87-100.63%
2025โ‚น137.12-34.08%
2024โ‚น208.013.72%
2023โ‚น200.55-323.96%
2022-โ‚น89.55220%
2021-โ‚น27.98-57.19%
2020-โ‚น65.37-44.38%
2019-โ‚น117.53
2017-โ‚น96.08-24.82%
2016-โ‚น127.79-9.87%
2015-โ‚น141.79660%
2014-โ‚น18.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น623.09-12,033,301,387,828,041,728.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น489.72-9,457,550,908,645,462,016.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น66.23-1,279,021,170,502,529,280.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น184.74-3,567,802,533,542,780,416.00%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น421.63-8,142,500,972,776,665,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น664.15-12,826,240,470,391,560,192.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-โ‚น4,693 90,630,359,278,848,229,376.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น41.98-810,647,220,741,039,872.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel